K. I. Birkeland - Concepedia

Author

K. I. Birkeland

Also Known As

Birkeland, K. I., K Birkeland, K I Birkeland, K. I. BIRKELAND, K. I. Birkeland, K.I. Birkeland, Karre I. Birkeland, Kåre I. Birkeland, S. Madsbad, V. F. Varillas

Publications

1.2K

Citations

H-Index

Concepts

All Affiliations

Oslo University Hospital Bærum Sykehus Akershus University Hospital

About

K. I. Birkeland is an author at Oslo University Hospital specializing in medicine, metabolic syndrome, and diabetes.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	276
2	Diabetes	3	3	264
3	Health Sciences	2	2	62
4	Clinical Nutrition	1	1	12
5	Endocrinology	1	1	50

K. I. Birkeland

Publications

962

Citations

H-Index

Page 1

	Year	Citations
Serum levels of advanced glycation end products are increased in patients with type 2 diabetes and coronary heart disease. Bente Kilhovd, Tore Julsrud Berg, K. I. Birkeland, Diabetes Care	1999	265
Lifestyle Changes May Reverse Development of the Insulin Resistance Syndrome. The Oslo Diet and Exercise Study: a randomized trial Peter A. Torjesen, K. I. Birkeland, Sigmund A. Anderssen, Diabetes Care	1997	199
Increased serum levels of the specific AGE-compound methylglyoxal-derived hydroimidazolone in patients with type 2 diabetes Bente Kilhovd, Ida Giardino, Peter A. Torjesen, Metabolism Metabolic SyndromeDiabetes ManagementDiabetesPharmacologyType 2	2003	186
Improved body composition after 8 wk of electrically stimulated leg cycling in tetraplegic patients Nils Hjeltnes, A. Aksnes, K. I. Birkeland, American Journal of Physiology-Regulatory, Integrative and Comparative Physiology	1997	129
Level of sex hormone-binding globulin is positively correlated with insulin sensitivity in men with type 2 diabetes K. I. Birkeland The Journal of Clinical Endocrinology & Metabolism Metabolic SyndromeInsulin SensitivityEndocrine MechanismDiabetesPhysiology	1993	50
An intensified lifestyle intervention programme may be superior to insulin treatment in poorly controlled Type 2 diabetic patients on oral hypoglycaemic agents: results of a feasibility study Abdulrahman Sherko M, Ingunn Bergstad, Per Medbøe Thorsby, Diabetic Medicine	2005	46
NIDDM: a rapid progressive disease Results from a long-term, randomised, comparative study of insulin or sulphonylurea treatment K. I. Birkeland, U Rishaug, Kristian F. Hanssen, Diabetologia Sulphonylurea TreatmentMetabolic SyndromeDiabetes ManagementInsulin ManagementDiabetes	1996	28
A long‐term, randomized, comparative study of insulin versus sulfonylurea therapy in type 2 diabetes K. I. Birkeland, Kristian F. Hanssen, Petter Urdal, Journal of Internal Medicine	1994	27
Effects of selective beta 2‐adrenoceptor blockade on serum potassium and exercise performance in normal men. Lars Gullestad, K. I. Birkeland, Gudmund Nordby, British Journal of Clinical Pharmacology	1991	20
Oral versus intravenous magnesium supplementation in patients with magnesium deficiency. Lars Gullestad, L Oystein Dolva, K. I. Birkeland, PubMed NutritionElderly PatientsMicronutrientsPharmacologyClinical Nutrition	1992	12

Page 1